Clinical Trial Update: Study Comparing Etanercept (ETN) Against a Placebo for Etanercept on a Background Nonsteroidal Anti Inflammatory Drug (NSAIDs) in the Treatment of Early Spondyloarthritis (SpA) Patients Who do Not Have X-ray Structural Changes [Phase 3]

View source ↗

Summary

Pfizer-sponsored Phase 3 trial comparing etanercept to placebo on background NSAIDs in early spondyloarthritis patients without radiographic changes completed a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis
• Nonradiographic Axial Spondyloarthritis
• Spondyloarthritis

Drugs mentioned

• Etanercept (etanercept)

Snippet

Sponsor: Pfizer | Conditions: Spondylitis, Ankylosing | Phase 3 | Status: COMPLETED | Results posted: 2015-10-19